Abstract:OBJECTIVE:To express and purify the human scFv antibody, SA3, against the hepatoma fused to enhanced green fluorescent protein, and to observe the targeted capacity of fusion protein EGFP-SA3 in vivo.METHODS:SA3 and EGFP genes were cloned into plasmid pET-25b(+) to construct the recombinant plasmid EGFP-SA3/pET-25b(+), followed by DNA sequencing. Then it was transformed into E.coli BL21(DE3) and induced for fusion expression of EGFP-SA3 with IPTG. The expressed fusion protein EGFP-SA3 was purified and detected with SDS-PAGE. HepG2 cells were incubated with the fusion protein EGFP-SA3 in vitro, and the binding bioactivity was observed under the fluorescent microscope. Further more, we injected the EGFP-SA3 by caudal vein into nude mice planted by hepatoma and observed the whole body fluorescence image of EGFP.RESULTS:SA3 and EGFP genes were successfully cloned into pET-25b(+), which was confirmed by restriction enzyme NcoI-XhoI or NcoI-EcoRI. A band migrated at the position 750 bp, same to EGFP gene, emerged when recombinant plasmid was digested by restriction enzyme NcoI-EcoRI. Similarly, a band, about 1 500 bp, emerged when digested by NcoI-XhoI. The open-reading frame was confirmed by DNA sequencing. Fusion protein EGFP-SA3 was expressed as inclusion body. After purification and refolding, the result of immunofluorescence detection verified that EGFP-SA3 could specifically bind to HepG2 cells and maximum tumor penetration was at 24 h after the injection.CONCLUSION:The purified fusion protein EGFP-SA3 has strong binding capacity to HepG2 cells, indicating the scFv SA3 has a potential value as a targeting molecule for diagnosis and targeted therapy for liver cancer.

Construction of eukaryotic expression plasmid of human Sesn3 gene and expression and localization of fusion protein in osteosarcoma cells

Construction and expression of 3*Flag-hSesn1 plasmid in osteosarcoma cells

Expression and localization of Sestrin2 in osteosarcoma cells

Construction of Eukaryotic Plasmid of Human hSesn1 Gene and Expression and Localization of Fusion Protein

Expression and localization of Polo-like kinase 3 in osteosarcoma cells

Construction,expression and localization of 3*Flag-hPlk4 plasmid in osteosarcoma cells

Construction of Recombinant Pegfp-N1-Hper2 Plasmid and Its Expression in Osteosarcoma Cells

Construction of Eukaryotic Expression Vector Containing B7-1/GFP Gene and Its Expression in Osteosarcoma Cell Line

Expression and Localization of Polo-like Kinase 2 in Osteosarcoma Cells

Expression and Localization of ArgBP2 in Osteosarcoma MG-63 Cells

Construction and identification of eukaryotic expression vector pEGFP-BLCAP

Expression and localization of Plk1 in osteosarcoma U2OS cells

Construction of Herg Shrna Expression Vectors and Establishment of Its Stably Transfected Osteosarcoma Cell Lines MG-63 and SOSP-9607

Construction of a Fusion Protein Expression Vector Pgs/2ss-M4gfp Without Antibiotic Resistance Gene and Its Subcellular Localization in Different Cell Lines.

Construction of Eukaryotic Expression Plasmid Pegfp-N3-m-il-2(88 Arg,125 Ala) and Its Effects on Glioma Cell Line U87

Construction of the eukaryotic expression vector expressing the fusion protein of human endostatin protein and IL3 signal peptide

Construction and Identification of Eukaryotic Expression Vector Bearing Mouse Ghrelin Receptor

Expression of Scfv SA3 Against Hepatoma Fused with Enhanced Green Fluorescent Protein and Its Targeted Ability in Vivo.

Construction of Eukaryotic Expression Plasmid of Human PRX3 and Its Expression in HEK-293FT Cells.

Construction of Eukaryote Polycistronic Expression Vector and Expression in Hela

Construction of Eukaryotic Expression Vector of Human TIM-3 Gene